TOKYO -- Japanese drugmaker Shionogi & Co. said Monday that it is developing a coronavirus vaccine with the help of insects and aiming to start clinical trials this year.
The technology behind the new medication was developed by Shionogi subsidiary UMN Pharma, a vaccine maker based in Akita, in northern Japan. The drugmaker is working with the health ministry in preparation for clinical trials. It hopes to eventually produce 10 million doses of the vaccine.
